Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 55
Filtrar
1.
J. bras. nefrol ; 43(2): 236-253, Apr.-June 2021. tab, graf
Artículo en Inglés, Portugués | LILACS | ID: biblio-1286935

RESUMEN

Abstract This nutrition consensus document is the first to coordinate the efforts of three professional organizations - the Brazilian Association of Nutrition (Asbran), the Brazilian Society of Nephrology (SBN), and the Brazilian Society of Parenteral and Enteral Nutrition (Braspen/SBNPE) - to select terminology and international standardized tools used in nutrition care. Its purpose is to improve the training delivered to nutritionists working with adult patients with chronic kidney disease (CKD). Eleven questions were developed concerning patient screening, care, and nutrition outcome management. The recommendations set out in this document were developed based on international guidelines and papers published in electronic databases such as PubMed, EMBASE(tm), CINHAL, Web of Science, and Cochrane. From a list of internationally standardized terms, twenty nutritionists selected the ones they deemed relevant in clinical practice involving outpatients with CKD. The content validity index (CVI) was calculated with 80% agreement in the answers. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework was used to assess the strength of evidence and recommendations. A total of 107 terms related to Nutrition Assessment and Reassessment, 28 to Diagnosis, nine to Intervention, and 94 to Monitoring and Evaluation were selected. The list of selected terms and identified tools will be used in the development of training programs and the implementation of standardized nutrition terminology for nutritionists working with patients with chronic kidney disease in Brazil.


Resumo Este consenso representa a primeira colaboração entre três organizações profissionais com foco em nutrição: Associação Brasileira de Nutrição (Asbran), Sociedade Brasileira de Nefrologia (SBN) e Sociedade Brasileira de Nutrição Parenteral e Enteral (Braspen/SBNPE), com o objetivo de identificar a terminologia e instrumentos padronizados internacionalmente para o processo de cuidado em nutrição. O foco é facilitar a condução de treinamentos de nutricionistas que trabalham com pacientes adultos com doenças renais crônicas (DRC). Foram levantadas onze questões relacionadas à triagem, ao processo de cuidado e à gestão de resultados em nutrição. As recomendações foram baseadas em diretrizes internacionais e em bancos de dados eletrônicos, como PubMed, EMBASE(tm), CINHAL, Web of Science e Cochrane. A partir do envio de listas de termos padronizados internacionalmente, vinte nutricionistas especialistas selecionaram aqueles que consideraram muito claros e relevantes para a prática clínica com pacientes ambulatoriais com DRC. Foi calculado o Índice de Validade de Conteúdo (IVC), com 80% de concordância nas respostas. O Grading of Recommendations, Assessment, Development and Evaluation (GRADE) foi usado para atribuir força de evidência às recomendações. Foram selecionados 107 termos de Avaliação e Reavaliação, 28 de Diagnóstico, 9 de Intervenção e 94 de Monitoramento e Aferição em Nutrição. A lista de termos selecionados e identificação de instrumentos auxiliará no planejamento de treinamentos e na implementação de terminologia padronizada em nutrição no Brasil, para nutricionistas que trabalham com pacientes renais crônicos.


Asunto(s)
Humanos , Adulto , Insuficiencia Renal Crónica , Nefrología , Evaluación Nutricional , Estado Nutricional , Consenso
2.
J Bras Nefrol ; 43(2): 236-253, 2021.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-33836040

RESUMEN

This nutrition consensus document is the first to coordinate the efforts of three professional organizations - the Brazilian Association of Nutrition (Asbran), the Brazilian Society of Nephrology (SBN), and the Brazilian Society of Parenteral and Enteral Nutrition (Braspen/SBNPE) - to select terminology and international standardized tools used in nutrition care. Its purpose is to improve the training delivered to nutritionists working with adult patients with chronic kidney disease (CKD). Eleven questions were developed concerning patient screening, care, and nutrition outcome management. The recommendations set out in this document were developed based on international guidelines and papers published in electronic databases such as PubMed, EMBASE(tm), CINHAL, Web of Science, and Cochrane. From a list of internationally standardized terms, twenty nutritionists selected the ones they deemed relevant in clinical practice involving outpatients with CKD. The content validity index (CVI) was calculated with 80% agreement in the answers. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework was used to assess the strength of evidence and recommendations. A total of 107 terms related to Nutrition Assessment and Reassessment, 28 to Diagnosis, nine to Intervention, and 94 to Monitoring and Evaluation were selected. The list of selected terms and identified tools will be used in the development of training programs and the implementation of standardized nutrition terminology for nutritionists working with patients with chronic kidney disease in Brazil.


Asunto(s)
Nefrología , Insuficiencia Renal Crónica , Adulto , Consenso , Humanos , Evaluación Nutricional , Estado Nutricional , Insuficiencia Renal Crónica/terapia
3.
J. bras. nefrol ; 43(1): 68-73, Jan.-Mar. 2021. tab, graf
Artículo en Inglés, Portugués | LILACS | ID: biblio-1154645

RESUMEN

Abstract Introduction: Point-of-care ultrasonography (US) (POCUS) has been used in several specialties, particularly in medical emergency. Despite the confirmation of its numerous benefits, the use of POCUS is still timid in nephrology. In the present study, we aim to investigate the use of POCUS by Brazilian nephrologists. Methods: A survey carried out among the members of the Brazilian Society of Nephrology, through institutional e-mail, using the SurveyMonkey platform. We included 12 self-administered questions, which answers were given anonymously. Results: It was evident that the majority (64%) of the participants did not have the opportunity to practice US during their nephrological training in their residency, specialization, or even in internships; those with experience with US use the method mainly for implanting central vascular accesses (68%), performing a renal biopsy (58%) and evaluating renal morphology (50%); and the main barriers for nephrologists who do not yet use US are the high price of US machines (26%) and the lack of time to learn about US (23%). Also, POCUS use for examinations of other organs, such as the lung (31%) and heart (18%), which are fundamental in the cardiovascular and volume assessment of patients with kidney diseases, is even more limited. However, 95% of the participants expressed an interest in learning POCUS for use in their medical practice. Conclusion: Most of the Brazilian nephrologists interviewed were not trained in US; however, almost all of the research participants expressed an interest in learning to use POCUS in nephrological practice.


Resumo Introdução: A ultrassonografia (US) pointof-care (POCUS) tem sido utilizada emvárias especialidades, particularmente na urgência médica. Apesar da constatação de seus numerosos benefícios, a utilização da POCUS ainda é tímida na nefrologia. No presente estudo, objetivamos fazer um levantamento sobre a utilização da POCUS pelos nefrologistas brasileiros. Métodos: Levantamento realizado entre os sócios da Sociedade Brasileira de Nefrologia, por meio do e-mail institucional, utilizando a plataforma SurveyMonkey. Foram incluídas 12 perguntas autoadministradas, cujas respostas se deram de forma anônima. Resultados: Ficou evidente que a maioria (64%) dos participantes não teve oportunidade de praticar a US durante sua formação nefrológica na residência, especialização ou mesmo em estágios; que aqueles com experiência com a US usam o método, principalmente, para implantação de acesso vascular central (68%), realização de biópsia renal (58%) e avaliação da morfologia renal (50%); e que as principais barreiras para os nefrologistas que ainda não utilizam a US são o preço elevado das máquinas de US (26%) e a falta de tempo para aprender sobre US (23%). Além disso, o uso da POCUS para exames de outros órgãos, como pulmão (31%) e coração (18%), fundamentais na avaliação cardiovascular e volêmica dos pacientes com doenças renais, ainda é mais limitado. Porém, 95% dos participantes expressaram interesse em aprender a POCUS para aplicação na sua prática médica. Conclusão: A maioria dos nefrologistas brasileiros entrevistados não foi treinada em US, contudo, a quase totalidade dos participantes da pesquisa manifestou interesse em aprender a utilizar a POCUS na prática nefrológica.


Asunto(s)
Humanos , Sistemas de Atención de Punto , Nefrología , Estudios Transversales , Ultrasonografía , Nefrólogos
4.
J Bras Nefrol ; 43(1): 68-73, 2021.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-33022029

RESUMEN

INTRODUCTION: Point-of-care ultrasonography (US) (POCUS) has been used in several specialties, particularly in medical emergency. Despite the confirmation of its numerous benefits, the use of POCUS is still timid in nephrology. In the present study, we aim to investigate the use of POCUS by Brazilian nephrologists. METHODS: A survey carried out among the members of the Brazilian Society of Nephrology, through institutional e-mail, using the SurveyMonkey platform. We included 12 self-administered questions, which answers were given anonymously. RESULTS: It was evident that the majority (64%) of the participants did not have the opportunity to practice US during their nephrological training in their residency, specialization, or even in internships; those with experience with US use the method mainly for implanting central vascular accesses (68%), performing a renal biopsy (58%) and evaluating renal morphology (50%); and the main barriers for nephrologists who do not yet use US are the high price of US machines (26%) and the lack of time to learn about US (23%). Also, POCUS use for examinations of other organs, such as the lung (31%) and heart (18%), which are fundamental in the cardiovascular and volume assessment of patients with kidney diseases, is even more limited. However, 95% of the participants expressed an interest in learning POCUS for use in their medical practice. CONCLUSION: Most of the Brazilian nephrologists interviewed were not trained in US; however, almost all of the research participants expressed an interest in learning to use POCUS in nephrological practice.


Asunto(s)
Nefrología , Sistemas de Atención de Punto , Estudios Transversales , Humanos , Nefrólogos , Ultrasonografía
6.
J Bras Nefrol ; 42(2 suppl 1): 4-8, 2020 Aug 26.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-32877490

RESUMEN

The Covid-19 pandemic brought several challenges to the healthcare system: diagnosis, treatment and measures to prevent the spread of the disease. With the greater availability and variety of diagnostic tests, it is essential to properly interpret them. This paper intends to help dialysis units concerning the use of clinical criteria and diagnostic tests for decision making regarding the discontinuation of isolation of patients with suspected or confirmed Covid-19, as well as the return to work activities for employees with suspected or confirmed Covid-19.


Asunto(s)
Betacoronavirus , Técnicas de Laboratorio Clínico/normas , Infecciones por Coronavirus/diagnóstico , Nefrología/normas , Neumonía Viral/diagnóstico , Diálisis Renal , Reinserción al Trabajo , Algoritmos , Brasil , COVID-19 , Prueba de COVID-19 , Lista de Verificación , Toma de Decisiones Clínicas , Técnicas de Laboratorio Clínico/métodos , Infecciones por Coronavirus/epidemiología , Humanos , Enfermedades Profesionales/diagnóstico , Pandemias , Aislamiento de Pacientes , Neumonía Viral/epidemiología , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Reacción en Cadena en Tiempo Real de la Polimerasa/normas , SARS-CoV-2 , Sociedades Médicas/normas , Servicio de Urología en Hospital/normas
7.
J Bras Nefrol ; 42(2 suppl 1): 9-11, 2020 Aug 26.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-32877491

RESUMEN

These recommendations were created after the publication of informative note 3/2020- CGGAP/DESF/SAPS/MS, of April 4, 2020, in which the Brazilian Ministry of Health recommended the use of a cloth mask by the population, in public places. Taking into account the necessary prioritization of the provision of Personal Protective Equipment (PPE) for patients with suspected or confirmed disease, as well as for healthcare professionals, the SBN is favorable concerning the wear of cloth masks by chronic kidney patients in dialysis, in public settings, except in the dialysis setting. The present recommendations have eleven items, related to this rationale, the procedures, indications, contraindications, as well as appropriate fabrics for the mask, and hygiene care to be adopted. These recommendations may change, at any time, in the light of new evidence.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/prevención & control , Máscaras/normas , Pandemias/prevención & control , Equipo de Protección Personal/normas , Neumonía Viral/prevención & control , Diálisis Renal , Textiles , Brasil , COVID-19 , Infecciones por Coronavirus/epidemiología , Personal de Salud , Humanos , Nefrología/normas , Enfermedades Profesionales/prevención & control , Neumonía Viral/epidemiología , Ropa de Protección/normas , Insuficiencia Renal Crónica/terapia , SARS-CoV-2 , Sociedades Médicas , Servicio de Urología en Hospital/normas
8.
J Bras Nefrol ; 42(2 suppl 1): 12-14, 2020 Aug 26.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-32877492

RESUMEN

Patients with Chronic Kidney Disease are among those individuals at increased risk for developing more serious forms of Covid-19. This increased risk starts in the pre-dialysis phase of the disease. Providing useful information for these patients, in language that facilitates the understanding of the disease, can help nephrologists and other healthcare professionals to establish a more effective communication with these patients and help minimize contagion and the risks of serious illness in this population.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/prevención & control , Pandemias/prevención & control , Educación del Paciente como Asunto/normas , Neumonía Viral/prevención & control , Insuficiencia Renal Crónica/complicaciones , Actividades Cotidianas , COVID-19 , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/epidemiología , Procedimientos Quirúrgicos Electivos , Higiene de las Manos/métodos , Higiene de las Manos/normas , Instituciones de Salud , Personal de Salud , Humanos , Nefrología/normas , Espacio Personal , Neumonía Viral/diagnóstico , Neumonía Viral/epidemiología , Diálisis Renal , Factores de Riesgo , SARS-CoV-2 , Evaluación de Síntomas
9.
J Bras Nefrol ; 42(2 suppl 1): 15-17, 2020 Aug 26.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-32877493

RESUMEN

Dialysis units are environments potentially prone to the spread of Covid-19. Patients cannot suspend treatment, and they often have comorbidities, which assigns them a higher risk and worse prognosis. The Brazilian Society of Nephrology prepared this document of good practices, whose technical recommendations deal with general measures that can be implemented to reduce the risk of transmission and prevent the spread of the disease in the unit.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/prevención & control , Pandemias/prevención & control , Neumonía Viral/prevención & control , Diálisis Renal/normas , Servicio de Urología en Hospital/normas , Brasil , COVID-19 , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/transmisión , Desinfección/métodos , Desinfección/normas , Humanos , Máscaras , Nefrología/normas , Aislamiento de Pacientes/métodos , Aislamiento de Pacientes/normas , Equipo de Protección Personal , Neumonía Viral/diagnóstico , Neumonía Viral/epidemiología , Neumonía Viral/transmisión , Insuficiencia Renal Crónica , SARS-CoV-2 , Sociedades Médicas/normas , Evaluación de Síntomas
10.
J Bras Nefrol ; 42(2 suppl 1): 18-21, 2020 Aug 26.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-32877494

RESUMEN

Considering the new coronavirus epidemic (Covid-19), the Brazilian Society of Nephrology, represented by the Peritoneal Steering Committee, in agreement with the and the Dialysis Department, developed a series of recommendations for good clinical practices for peritoneal dialysis (PD) clinics, to be considered during the period of the Covid-19 epidemic. We aim to minimize the disease spread, protecting patients and staff, and ensuring the quality of the treatment provided and adequate follow-up for PD patients. The recommendations suggested at this moment must be adapted to each clinic's reality and the conditions of the structural and human resources, dependent on the adequate financial provision of the public health system for its full implementation.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/prevención & control , Fallo Renal Crónico/terapia , Pandemias/prevención & control , Diálisis Peritoneal/normas , Neumonía Viral/prevención & control , Brasil , COVID-19 , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/epidemiología , Desinfección/métodos , Desinfección/normas , Humanos , Fallo Renal Crónico/complicaciones , Máscaras , Nefrología/normas , Enfermedades Profesionales/prevención & control , Grupo de Atención al Paciente , Educación del Paciente como Asunto , Aislamiento de Pacientes/métodos , Aislamiento de Pacientes/normas , Diálisis Peritoneal/instrumentación , Diálisis Peritoneal/métodos , Equipo de Protección Personal , Neumonía Viral/diagnóstico , Neumonía Viral/epidemiología , SARS-CoV-2 , Sociedades Médicas , Telemedicina/legislación & jurisprudencia , Telemedicina/métodos , Telemedicina/normas , Servicio de Urología en Hospital/organización & administración , Servicio de Urología en Hospital/normas
11.
J Bras Nefrol ; 42(2 suppl 1): 22-31, 2020 08 26.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-32877495

RESUMEN

We produced this document to bring pertinent information to the practice of nephrology, as regards to the renal involvement with COVID-19, the management of acute kidney injury cases, and practical guidance on the provision of dialysis support.As information on COVID-19 evolves at a pace never before seen in medical science, these recommendations, although based on recent scientific evidence, refer to the present moment. The guidelines may be updated when published data and other relevant information become available.


Asunto(s)
Lesión Renal Aguda/terapia , Betacoronavirus , Infecciones por Coronavirus/epidemiología , Neumonía Viral/epidemiología , Terapia de Reemplazo Renal/normas , Dispositivos de Acceso Vascular/normas , Lesión Renal Aguda/epidemiología , Lesión Renal Aguda/etiología , Brasil/epidemiología , COVID-19 , Toma de Decisiones Clínicas , Infecciones por Coronavirus/tratamiento farmacológico , Infecciones por Coronavirus/prevención & control , Cuidados Críticos , Humanos , Riñón/efectos de los fármacos , Nefrología/normas , Enfermedades Profesionales/prevención & control , Pandemias/prevención & control , Equipo de Protección Personal , Neumonía Viral/tratamiento farmacológico , Neumonía Viral/prevención & control , Recuperación de la Función , Terapia de Reemplazo Renal/métodos , Respiración Artificial/efectos adversos , SARS-CoV-2 , Sociedades Médicas
12.
J Bras Nefrol ; 42(2 suppl 1): 49-50, 2020 Aug 26.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-32877501

RESUMEN

Chloroquine and hydroxychloroquine have shown promising preliminary results and have been discussed as therapeutic options for patients with Covid-19. Despite the lack of robust evidence demonstrating the benefits and justifying the use of one of these drugs, the final decision is the responsibility of the attending physician and should be individualized and shared, whenever possible. This position statement recommends dosage adjustment for these drugs in the context of renal impairment.


Asunto(s)
Antimaláricos/administración & dosificación , Cloroquina/administración & dosificación , Infecciones por Coronavirus/tratamiento farmacológico , Hidroxicloroquina/administración & dosificación , Neumonía Viral/tratamiento farmacológico , Insuficiencia Renal , Brasil , COVID-19 , Humanos , Nefrología , Pandemias , Sociedades Médicas , Tratamiento Farmacológico de COVID-19
13.
J. bras. nefrol ; 42(2,supl.1): 22-31, 2020. tab
Artículo en Inglés | LILACS | ID: biblio-1134827

RESUMEN

ABSTRACT We produced this document to bring pertinent information to the practice of nephrology, as regards to the renal involvement with COVID-19, the management of acute kidney injury cases, and practical guidance on the provision of dialysis support.As information on COVID-19 evolves at a pace never before seen in medical science, these recommendations, although based on recent scientific evidence, refer to the present moment. The guidelines may be updated when published data and other relevant information become available.


RESUMO Este documento foi desenvolvido para trazer informações pertinentes à prática nefrológica em relação ao conhecimento sobre o acometimento renal da COVID-19, conduta frente aos casos de injúria renal aguda e orientações práticas sobre a provisão do suporte dialítico.Como as informações sobre a COVID-19 evoluem a uma velocidade jamais vista na ciência médica, as orientações apresentadas, embora baseadas em evidências científicas recentes, referem-se ao momento presente. Essas orientaços poderão ser atualizadas à medida que dados publicados e outras informações relevantes venham a ser disponibilizadas.


Asunto(s)
Humanos , Neumonía Viral/epidemiología , Terapia de Reemplazo Renal/normas , Infecciones por Coronavirus/epidemiología , Lesión Renal Aguda/terapia , Dispositivos de Acceso Vascular/normas , Betacoronavirus , Respiración Artificial/efectos adversos , Sociedades Médicas , Brasil/epidemiología , Infecciones por Coronavirus/prevención & control , Infecciones por Coronavirus/tratamiento farmacológico , Recuperación de la Función , Cuidados Críticos , Lesión Renal Aguda/etiología , Lesión Renal Aguda/epidemiología , Toma de Decisiones Clínicas , SARS-CoV-2 , COVID-19 , Enfermedades Profesionales/prevención & control
14.
J. bras. nefrol ; 42(2,supl.1): 18-21, 2020.
Artículo en Inglés | LILACS | ID: biblio-1134829

RESUMEN

ABSTRACT Considering the new coronavirus epidemic (Covid-19), the Brazilian Society of Nephrology, represented by the Peritoneal Steering Committee, in agreement with the and the Dialysis Department, developed a series of recommendations for good clinical practices for peritoneal dialysis (PD) clinics, to be considered during the period of the Covid-19 epidemic. We aim to minimize the disease spread, protecting patients and staff, and ensuring the quality of the treatment provided and adequate follow-up for PD patients. The recommendations suggested at this moment must be adapted to each clinic's reality and the conditions of the structural and human resources, dependent on the adequate financial provision of the public health system for its full implementation.


RESUMO Considerando a nova epidemia de coronavírus (Covid-19), a Sociedade Brasileira de Nefrologia, representada pelo Comitê de Diálise Peritoneal, em concordância com a diretoria e o Departamento de Diálise, desenvolveu uma série de recomendações de boas práticas clínicas para os serviços de diálise peritoneal a serem consideradas durante o período da epidemia de Covid-19, com o objetivo de minimizar a disseminação da doença, proteger pacientes e funcionários e garantir a qualidade do tratamento prestado e acompanhamento adequado para os pacientes em DP. As recomendações aqui sugeridas devem ser adaptadas a cada realidade de serviço e às condições estruturais e de recursos humanos e dependem da provisão financeira adequada do sistema público de saúde para sua plena implementação.


Asunto(s)
Humanos , Neumonía Viral/prevención & control , Diálisis Peritoneal/normas , Infecciones por Coronavirus/prevención & control , Pandemias/prevención & control , Betacoronavirus , Fallo Renal Crónico/terapia , Brasil , Desinfección/métodos , Servicio de Urología en Hospital/normas , Telemedicina/normas , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/epidemiología , Equipo de Protección Personal , SARS-CoV-2 , COVID-19
15.
J. bras. nefrol ; 42(2,supl.1): 49-50, 2020.
Artículo en Inglés | LILACS | ID: biblio-1134830

RESUMEN

ABSTRACT Chloroquine and hydroxychloroquine have shown promising preliminary results and have been discussed as therapeutic options for patients with Covid-19. Despite the lack of robust evidence demonstrating the benefits and justifying the use of one of these drugs, the final decision is the responsibility of the attending physician and should be individualized and shared, whenever possible. This position statement recommends dosage adjustment for these drugs in the context of renal impairment.


RESUMO Em razão de resultados preliminares promissores, a hidroxicloroquina e a cloroquina têm sido discutidas como opção terapêutica para pacientes com Covid-19. Apesar da ausência de estudos robustos que evidenciem o benefício e justifiquem o uso de uma dessas drogas, a decisão final compete ao médico assistente, devendo ser individualizada e, sempre que possível, compartilhada. A presente nota pretende orientar o ajuste posológico dessas drogas no contexto da disfunção renal.


Asunto(s)
Humanos , Neumonía Viral/tratamiento farmacológico , Cloroquina/administración & dosificación , Infecciones por Coronavirus/tratamiento farmacológico , Insuficiencia Renal , Hidroxicloroquina/administración & dosificación , Antimaláricos/administración & dosificación , Sociedades Médicas , Brasil , Pandemias , COVID-19 , Nefrología
16.
J. bras. nefrol ; 42(2,supl.1): 4-8, 2020. graf
Artículo en Inglés | LILACS | ID: biblio-1134833

RESUMEN

ABSTRACT The Covid-19 pandemic brought several challenges to the healthcare system: diagnosis, treatment and measures to prevent the spread of the disease. With the greater availability and variety of diagnostic tests, it is essential to properly interpret them. This paper intends to help dialysis units concerning the use of clinical criteria and diagnostic tests for decision making regarding the discontinuation of isolation of patients with suspected or confirmed Covid-19, as well as the return to work activities for employees with suspected or confirmed Covid-19.


RESUMO A pandemia da Covid-19 trouxe desafios ao sistema de saúde em diversas esferas: diagnóstico, tratamento e medidas para evitar a disseminação da doença. Com a maior disponibilização e variedades de testes diagnósticos, torna-se fundamental sua adequada interpretação. Este posicionamento pretende orientar unidades de diálise em relação ao uso de critérios clínicos e testes diagnósticos para a tomada de decisão referente à descontinuação do isolamento de pacientes com suspeita ou confirmação de Covid-19, assim como para o retorno às atividades laborais de colaboradores com suspeita ou confirmação de Covid-19.


Asunto(s)
Humanos , Neumonía Viral/diagnóstico , Diálisis Renal , Infecciones por Coronavirus/diagnóstico , Técnicas de Laboratorio Clínico/normas , Reinserción al Trabajo , Betacoronavirus , Nefrología/normas , Aislamiento de Pacientes , Neumonía Viral/epidemiología , Sociedades Médicas/normas , Algoritmos , Brasil , Servicio de Urología en Hospital/normas , Técnicas de Laboratorio Clínico/métodos , Lista de Verificación , Pandemias , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Toma de Decisiones Clínicas , Prueba de COVID-19 , SARS-CoV-2 , COVID-19
18.
J. bras. nefrol ; 42(2,supl.1): 9-11, 2020.
Artículo en Inglés | LILACS | ID: biblio-1134835

RESUMEN

ABSTRACT These recommendations were created after the publication of informative note 3/2020- CGGAP/DESF/SAPS/MS, of April 4, 2020, in which the Brazilian Ministry of Health recommended the use of a cloth mask by the population, in public places. Taking into account the necessary prioritization of the provision of Personal Protective Equipment (PPE) for patients with suspected or confirmed disease, as well as for healthcare professionals, the SBN is favorable concerning the wear of cloth masks by chronic kidney patients in dialysis, in public settings, except in the dialysis setting. The present recommendations have eleven items, related to this rationale, the procedures, indications, contraindications, as well as appropriate fabrics for the mask, and hygiene care to be adopted. These recommendations may change, at any time, in the light of new evidence.


RESUMO As presentes recomendações foram elaboradas após a publicação da Nota Informativa nº 3/2020 CGGAP/DESF/SAPS/MS, em 4 de abril de 2020, na qual o Ministério da Saúde recomenda o uso de máscara de pano por toda a população, em locais públicos. Levando-se em consideração a necessária priorização do fornecimento de Equipamentos de Proteção Individual (EPIs) para pacientes com suspeita ou confirmação da doença, assim como para profissionais de saúde, a Sociedade Brasileira de Nefrologia (SBN) posicionou-se favoravelmente ao uso de máscaras de pano por pacientes renais crônicos em diálise, em ambientes públicos, exceto no ambiente da diálise. As presentes recomendações englobam onze itens relativos ao que é racional para posicionamento, procedimentos, indicações, contraindicações, assim como tecidos apropriados para confecção e os cuidados de higiene a serem adotados. Essas recomendações poderão ser modificadas a qualquer momento, à luz de novas evidências.


Asunto(s)
Humanos , Neumonía Viral/prevención & control , Textiles , Diálisis Renal , Infecciones por Coronavirus/prevención & control , Pandemias/prevención & control , Equipo de Protección Personal/normas , Betacoronavirus , Máscaras/normas , Neumonía Viral/epidemiología , Ropa de Protección/normas , Sociedades Médicas , Brasil , Servicio de Urología en Hospital/normas , Personal de Salud , Infecciones por Coronavirus/epidemiología , Insuficiencia Renal Crónica/terapia , SARS-CoV-2 , COVID-19 , Nefrología/normas , Enfermedades Profesionales/prevención & control
19.
J. bras. nefrol ; 42(2,supl.1): 12-14, 2020.
Artículo en Inglés | LILACS | ID: biblio-1134836

RESUMEN

ABSTRACT Patients with Chronic Kidney Disease are among those individuals at increased risk for developing more serious forms of Covid-19. This increased risk starts in the pre-dialysis phase of the disease. Providing useful information for these patients, in language that facilitates the understanding of the disease, can help nephrologists and other healthcare professionals to establish a more effective communication with these patients and help minimize contagion and the risks of serious illness in this population.


RESUMO Pacientes com Doença Renal Crônica estão entre os indivíduos de risco aumentado para desenvolvimento de formas mais sérias de Covid-19. Esse risco aumentado inicia-se já na fase pré-dialítica da doença. Fornecer informações úteis para esses pacientes, em linguagem que facilite o entendimento da doença, pode ajudar nefrologistas e outros profissionais de saúde a estabelecerem uma comunicação mais efetiva com esses pacientes e ajudar a minimizar o contágio e os riscos de doença grave nessa população.


Asunto(s)
Humanos , Neumonía Viral/prevención & control , Educación del Paciente como Asunto/normas , Infecciones por Coronavirus/prevención & control , Insuficiencia Renal Crónica/complicaciones , Pandemias/prevención & control , Betacoronavirus , Espacio Personal , Neumonía Viral/diagnóstico , Actividades Cotidianas , Factores de Riesgo , Diálisis Renal , Personal de Salud , Procedimientos Quirúrgicos Electivos , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/epidemiología , Evaluación de Síntomas , Higiene de las Manos/métodos , Higiene de las Manos/normas , SARS-CoV-2 , COVID-19 , Instituciones de Salud , Nefrología/normas
20.
J. bras. nefrol ; 41(4): 539-549, Out.-Dec. 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1056608

RESUMEN

Abstract According to data from the last census of the Brazilian Society of Nephrology (SBN), the prevalence of hepatitis C virus (HCV) in Brazilian hemodialysis units (HU) is 3.3%, about three times higher than what is reported for the Brazilian general population. Often, professionals working in HU are faced with clinical situations that require rapid HCV diagnosis in order to avoid horizontal transmission within the units. On the other hand, thanks to the development of new antiviral drugs, the cure of patients with HCV, both in the general population and in patients with chronic kidney disease and the disease eradication, appear to be very feasible objectives to be achieved in the near future . In this scenario, SBN and the Brazilian Society of Hepatology present in this review article a proposal to approach HCV within HUs.


Resumo De acordo com os dados do último censo da Sociedade Brasileira de Nefrologia (SBN), a prevalência de portadores do vírus da hepatite C (HCV) nas unidades de hemodiálise (UH) no Brasil é de 3,3%, cerca de três vezes maior do que é observado na população geral brasileira. Muitas vezes, os profissionais que trabalham nas UH deparam-se com situações clínicas que demandam rápido diagnóstico do HCV, a fim de evitar uma transmissão horizontal dentro das unidades. Por outro lado, a cura dos pacientes portadores do HCV, tanto na população geral como na portadora de doença renal crônica e a erradicação da doença, em virtude do desenvolvimento de novas drogas antivirais, parecem ser objetivos bastante factíveis, a ser alcançados em futuro próximo. Nesse cenário, a SBN e a Sociedade Brasileira de Hepatologia apresentam neste artigo de revisão uma proposta de abordagem do HCV dentro das UH.


Asunto(s)
Humanos , Diálisis Renal/estadística & datos numéricos , Hepatitis C/epidemiología , Transmisión de Enfermedad Infecciosa/prevención & control , Insuficiencia Renal Crónica/terapia , Antivirales/uso terapéutico , Virus ARN/genética , Brasil/epidemiología , Infección Hospitalaria/transmisión , Prevalencia , Hepatitis C/diagnóstico , Hepatitis C/tratamiento farmacológico , Hepacivirus/efectos de los fármacos , Hepacivirus/genética , Tasa de Filtración Glomerular/fisiología , Nefrología/organización & administración , Nefrología/estadística & datos numéricos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA